Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder of Lipid Storage and Metabolism”

490 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 490 results

Not applicableStudy completedNCT01358370
What this trial is testing

A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype

Who this might be right for
Lysosomal Acid Lipase DeficiencyWolman Disease
Alexion Pharmaceuticals, Inc. 40
Not applicableUnknownNCT02843334
What this trial is testing

Study of the Prevalence of Fabry Disease in French Dialysis Patients

Who this might be right for
Fabry DiseaseEnd Stage Renal DiseaseRenal Dialysis
Hospices Civils de Lyon 6,000
Not applicableUnknownNCT04324775
What this trial is testing

Comparison of Acute Effect of Different Manual Techniques on Muscle Fascia Stiffness

Who this might be right for
Manual Lymphatic DrainageSwedish MassageMuscle Fascia Stiffness
Marmara University 30
Large-scale testing (Phase 3)Study completedNCT00925301
What this trial is testing

Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease

Who this might be right for
Fabry Disease
Amicus Therapeutics 67
Testing effectiveness (Phase 2)Study completedNCT00071877
What this trial is testing

An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease

Who this might be right for
Fabry Disease
National Institute of Neurological Disorders and Stroke (NINDS) 25
Not applicableStudy completedNCT00351156
What this trial is testing

Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease

Who this might be right for
Gaucher Disease
Amicus Therapeutics 50
Not applicableWithdrawnNCT05755568
What this trial is testing

Learn About Metachromatic Leukodystrophy (MLD) in Children in Spain

Who this might be right for
Metachromatic Leukodystrophy (MLD)
Takeda
Not applicableActive Not RecruitingNCT01911091
What this trial is testing

Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)

Who this might be right for
ObesityDisorder of Lipid Storage and MetabolismLipid Metabolism Disorders+1 more
AdventHealth Translational Research Institute 56
Testing effectiveness (Phase 2)UnknownNCT05710367
What this trial is testing

Effects Of Sodium Glucose Cotranspoter 2 Inhibitors On Heart And Kidneys In Fabry Disease Patients

Who this might be right for
Fabry Disease
Albina Nowak, MD 46
Large-scale testing (Phase 3)Study completedNCT01074944
What this trial is testing

Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)

Who this might be right for
Gaucher Disease
Genzyme, a Sanofi Company 170
Early research (Phase 1)UnknownNCT03893071
What this trial is testing

Open-Label Study of Long-Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann-Pick Disease Type C

Who this might be right for
Niemann-Pick Disease, Type C1
Cyclo Therapeutics, Inc. 12
Not applicableUnknownNCT02859363
What this trial is testing

Fabry Disease in Cerebrovascular Disease

Who this might be right for
Fabry Disease
Chang Gung Memorial Hospital 700
Testing effectiveness (Phase 2)Study completedNCT00214500
What this trial is testing

AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

Who this might be right for
Fabry Disease
Amicus Therapeutics 9
Not applicableStudy completedNCT05106764
What this trial is testing

Early Detection of Fabry Disease

Who this might be right for
Fabry Disease
Takeda 50
Not applicableActive Not RecruitingNCT07274826
What this trial is testing

Diagnostic Creteria of Acid Sphingomyelinase Deficiency (ASMD)

Who this might be right for
Acid Sphingomyelinase Deficiency (ASMD)
Sohag University 7
Early research (Phase 1)Looking for participantsNCT03721068
What this trial is testing

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

Who this might be right for
NeuroblastomaOsteosarcoma
UNC Lineberger Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT02489344
What this trial is testing

Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 8
Testing effectiveness (Phase 2)Study completedNCT01102686
What this trial is testing

Pyrimethamine as a Treatment for Late-Onset GM2-gangliosidosis (Tay-Sachs and Sandhoff Disease)

Who this might be right for
Gangliosidoses, GM2Sandhoff DiseaseTay-Sachs Disease
The Hospital for Sick Children 20
Not applicableStudy completedNCT05409846
What this trial is testing

Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies

Who this might be right for
Fabry Disease
Universidade do Porto 409
Testing effectiveness (Phase 2)Study completedNCT04046224
What this trial is testing

Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR)

Who this might be right for
Fabry Disease
Sangamo Therapeutics 36
Next Page